Market Overview

The global duck medicine and vaccines market size was valued at USD 1,750 million in 2022 and is projected to reach around USD 3,200 million in 2033 exhibiting a CAGR of 7.5% in the forecasted period. The rising demand of the poultry industry, growing prevalence of diseases of duck, and surging research and development activities are anticipated to boost the market growth. However, high cost involved in the treatment, limited access to the vaccines in developing nations are the factors hindering the growth of the market in the forecasted period.

Report Scope

The growing prevalence of viral and bacterial infectious diseases in ducks is anticipated to drive market growth during the forecast period. For instance, as per an article published by Science Direct in September 2021, duck diseases were underreported between 2000 and 2007, but some reports on disease prevalence showed a gradual increase from 2008 to 2015.

Key Companies

·         Boehringer Ingelheim International Gmbh

·         Ceva

·         YEBIO BIOENGINEERING CO., LTD.

·         NAVETCO

·         Shangqiu Meilan Biological Engineering Co., Ltd.

·         Merck & Co., Inc.

·         EGAVET

·         Bioveta, a.s.

·         Jilin Zhengye Biological Products company limited

·         Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.

·         Other players

Moreover, the rising growth plans such as construction of novel labs by the market companies set up in the market to increase the immunizer development is estimated to boost development of the global duck medicine and vaccines market during the anticipated duration. For example, in June 2021, YEBIO BIOENGINEERING CO., LTD developed Yebio High-grade Pathogen Biosafety Grade 3 Labs. This Labs includes working sections such as tissue-level labs and workshops for enormous and normal-sized and small animals, which can be used for pathogen segregation, trial investigations for inhibition and control surveys on illness such as African swine fever and avian influenza.

The coronavirus pandemic has negatively impacted the production, development, and supply of medicines and the growth of the pharmaceutical businesses of several companies across the world. The lockdown has caused in the closure of industrial establishments, excluding the manufacturing of essential supplies and there has been disturbance in the supply chain of pharmaceuticals. Thus, the COVID-19 pandemic has affected the economy in three main ways, by directly affecting the production and demand; by disrupting distribution channels; and by causing financial impact on firms and financial markets. The supply chain and manufacturing activities in China, India, and the U.S. are disturbed due to the global lockdown, while many nations, such as Egypt, Saudi Arabia, the UAE, and others, are facing problems with respect to the transport of drugs from one place to another. Due to all the above reasons, the growth of global duck medicines and vaccines market was adversely hampered.

Type Insights

The vaccines segment led the market for duck medicine and vaccines and accounted for the largest revenue share of around 69% in 2021 over the forecast period, due to the routine vaccinations carried out for the anticipation of diseases in ducks. Diseases such as duck viral hepatitis, duck plague, and others, have no cure available and hence vaccination is the only way to avoid such diseases. For instance, duck viral hepatitis majorly affects ducklings of 2 to 3 weeks of age and there is no treatment option existing and so they can be vaccinated by an attenuated strain of virus before the beginning of egg production.

Application Insights

On the basis of application, the market is segmented into farm and application. In 2021, the farm segment ruled the market for duck medicine and vaccines and held the largest market share of 38%. For instance, as per the data provided by Sentient Media, a non-profit news organization, in January 2022, ducks can work as a vital source for providing eggs or meat in the farms.

Region Insights

North America market dominated the global duck medicine and vaccines market in terms of demand and industry share. This trend can be accredited due to the existence of high number of important industry players as well as the awareness regarding poultry animals in the region. Moreover, the increasing duck farming will boost the growth of the duck medicine and vaccines market in this region.

However, Asia-Pacific is anticipated to grow during the forecasted period owing to increasing duck farm and rising awareness regarding medicines and vaccines for poultry animals in this region.

Key Companies Insights

The market for duck medicine and vaccines is moderately competitive. With the rising applications of duck medicine and vaccines, new players are considering to enter the market. The companies are also involved in activities like joint ventures, acquisitions, partnerships, mergers, and collaborations. These activities aid in growing the effect of the players in the duck medicine and vaccines market, ultimately boosting the market growth. Some of the key companies working in the global duck medicine and vaccines market include:

Some of the Recent Developments:

• In June 2021, YEBIO BIOENGINEERING CO., LTD developed Yebio High-grade Pathogen Biosafety Grade 3 Labs.

• In September 2020, scientists at the Department of Veterinary Microbiology, Kerala Veterinary and Animal Sciences University (KVASU), Mannuthy, a university intending to promote sustainable and profitable animal production systems, developed a vaccine for Riemerellosis, a bacterial disease that causes significant mortality in ducks.

Why to buy this Report?

Market research: The report provides valuable insights into market trends, growth opportunities, and competitive landscapes. By reading a technology report, businesses and investors can gain a better understanding of the market they are operating in or considering entering, and make more informed decisions based on data and analysis.

Competitive analysis: The report reports provide detailed information on competitors' strengths, weaknesses, and strategies, which can help businesses identify potential threats and opportunities in the market.

Innovation: The report provides insights into emerging technologies and trends, which can help businesses stay up-to-date with the latest developments and make informed decisions about where to invest their resources.

Due diligence: The report can be used by investors and acquirers as part of their due diligence process when considering investing in or acquiring a technology company. These reports can provide valuable information on the company's financials, technology, market position, and other key factors.

Segments

By Type

• Medicine

• Vaccines

By Application

• Farms

• Applications

By Geography

• North America

o U.S.

o Canada

o Mexico

• Europe

o U.K.

o Germany

o France

o Italy

o Spain

o Russia

• Asia-Pacific

o Japan

o China

o India

o Australia

o South Korea

o ASEAN

• Latin America

o Brazil

o Argentina

o Colombia

• MEA

o South Africa

o Saudi Arabia

o UAE

o Egypt

Key FAQ’s

What is the market size and growth projections?

• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?

• What are the top performing segments, and countries / regions of each of the markets?

• What is the market size and growth rate across key countries / regions?

• How big is the global & regional market in terms of revenue?

• How far market will grow in forecast period in terms of revenue?

• What factors will influence demand and supply trends across each markets during the forecast period?

• What are the technology trends shaping various markets?

• Which country / region has more opportunities?

• What is the COVID-19 impact on the market and how long will it take to recover?

• Who are the key competitors of market Players?

• What are the market share (%) of Key Players?

• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?

• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?